BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2021;1:CD012768. [PMID: 33448348 DOI: 10.1002/14651858.CD012768.pub3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Klein M. Bakterielle Meningitis und Neurotuberkulose. Neurologie up2date 2022;05:321-338. [DOI: 10.1055/a-1716-7500] [Reference Citation Analysis]
2 Shivakumar P, Sunil Shettigar K. Tuberculosis Diagnosis: Updates and Challenges. Mycobacterium - Epidemiology, Prevention, Diagnostic, and Management [Working Title] 2022. [DOI: 10.5772/intechopen.107168] [Reference Citation Analysis]
3 Tang P, Liu R, Qin L, Xu P, Xiong Y, Deng Y, Lv Z, Shang Y, Gao X, Yao L, Zhang R, Feng Y, Ding C, Jing H, Li L, Tang Y, Pang Y. Accuracy of Xpert® MTB/RIF Ultra test for posterior oropharyngeal saliva for the diagnosis of paucibacillary pulmonary tuberculosis: a prospective multicenter study. Emerging Microbes & Infections 2022. [DOI: 10.1080/22221751.2022.2148564] [Reference Citation Analysis]
4 Wang Z, Guo T, Jiang T, Zhao Z, Zu X, li L, Zhang Q, Hou Y, Song K, Xue Y. Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis. BMC Infect Dis 2022;22:812. [DOI: 10.1186/s12879-022-07792-7] [Reference Citation Analysis]
5 Byanyima P, Kaswabuli S, Musisi E, Nabakiibi C, Zawedde J, Sanyu I, Sessolo A, Andama A, Worodria W, Huang L, Davis JL. Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda. Microbiol Spectr 2022;:e0086022. [PMID: 36154664 DOI: 10.1128/spectrum.00860-22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kay AW, Ness T, Verkuijl SE, Viney K, Brands A, Masini T, González Fernández L, Eisenhut M, Detjen AK, Mandalakas AM, Steingart KR, Takwoingi Y. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd013359.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nandlal L, Perumal R, Naidoo K. . IDR 2022;Volume 15:4971-84. [DOI: 10.2147/idr.s381643] [Reference Citation Analysis]
8 Abdulgader SM, Okunola AO, Ndlangalavu G, Reeve BWP, Allwood BW, Koegelenberg CFN, Warren RM, Theron G. Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do? Respiration 2022;:1-17. [PMID: 35760050 DOI: 10.1159/000525142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Soni A, Guliani A, Nehra K, Mehta PK. Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests. Expert Rev Respir Med 2022. [PMID: 35728039 DOI: 10.1080/17476348.2022.2093189] [Reference Citation Analysis]
10 Ssebambulidde K, Gakuru J, Ellis J, Cresswell FV, Bahr NC. Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet? Front Neurol 2022;13:892224. [PMID: 35711276 DOI: 10.3389/fneur.2022.892224] [Reference Citation Analysis]
11 Tahseen S, Ambreen A, Ishtiaq S, Khanzada FM, Safdar N, Sviland L, Mustafa T. The value of histological examination in the diagnosis of tuberculous lymphadenitis in the era of rapid molecular diagnosis. Sci Rep 2022;12:8949. [PMID: 35624128 DOI: 10.1038/s41598-022-12660-0] [Reference Citation Analysis]
12 Yu G, Wang L, Shen Y, Fang L, Yang J, Ye B, Xu K, Zhong F. Comparison of the Diagnostic Accuracy of Xpert MTB/RIF and CapitalBio Mycobacterium RT-PCR Detection Assay for Tuberculous Pericarditis. IDR 2022;Volume 15:2127-35. [DOI: 10.2147/idr.s360064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shen Y, Fang L, Ye B, Xu X, Yu G, Zhou L. The Role of Core Needle Biopsy Pathology Combined with Molecular Tests in the Diagnosis of Lymph Node Tuberculosis. IDR 2022;Volume 15:335-45. [DOI: 10.2147/idr.s350570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Antonello M, Scutari R, Lauricella C, Renica S, Motta V, Torri S, Russo C, Gentile L, Cento V, Colagrossi L, Mattana G, Codecasa LR, Vismara C, Scaglione F, Veronese SM, Bonoldi E, Bandera A, Gori A, Mazzola E, Perno CF, Alteri C. Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study. Front Microbiol 2021;12:727774. [PMID: 34589075 DOI: 10.3389/fmicb.2021.727774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Engel N, Ochodo EA, Karanja PW, Schmidt B, Janssen R, Steingart KR, Oliver S. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nathavitharana RR, Lederer P, Chaplin M, Bjerrum S, Steingart KR, Shah M. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV. Cochrane Database Syst Rev 2021;8:CD014641. [PMID: 34416013 DOI: 10.1002/14651858.CD014641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
17 Basu S, Shetty A. Laboratory Diagnosis of Tropical Infections. Indian J Crit Care Med 2021;25:S122-6. [PMID: 34345124 DOI: 10.5005/jp-journals-10071-23813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Poudel D, Poudel D, Poudel D. Use of alternative cerebrospinal fluid-based biomarkers to help diagnose Xpert-negative tuberculous meningitis: A case report. Clin Case Rep 2021;9:e04526. [PMID: 34322264 DOI: 10.1002/ccr3.4526] [Reference Citation Analysis]
19 MacLean E, Nathavitharana RR. Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA. J Clin Microbiol 2021;59:e0070621. [PMID: 33980646 DOI: 10.1128/JCM.00706-21] [Reference Citation Analysis]
20 Bisognin F, Lombardi G, Felici S, Monte PD. MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria. Sci Rep 2021;11:13706. [PMID: 34211059 DOI: 10.1038/s41598-021-93182-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gopalaswamy R, Dusthackeer VNA, Kannayan S, Subbian S. Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance. JoR 2021;1:141-64. [DOI: 10.3390/jor1020015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Burch J, Ciapponi A. With culture used as the reference standard, what is the accuracy of the Xpert® MTB/RIF assay for detecting extrapulmonary tuberculosis (TB) using cerebrospinal fluid, pleural fluid, lymph node aspirate, or urine? Cochrane Clinical Answers 2021. [DOI: 10.1002/cca.3093] [Reference Citation Analysis]
23 Burch J, Ciapponi A. What is the accuracy of the Xpert® MTB/RIF assay for detecting rifampicin resistance? Cochrane Clinical Answers 2021. [DOI: 10.1002/cca.3090] [Reference Citation Analysis]